1Adler AL,,Stratton IM’Neil HA,et al.Association of systolic bloodpressurewith macrovascular and microvascular complications of type 2 dia-betes(UKPDS 36):prospective observational study.British Medical Journal.2000(37):49-56.
2Bamford J,Sandercock P,Dennis M,et al.Classification and natural historyof clinically identifiable subtypes of cerebral infarction.The Lancet.1991,12(4):103-112.
1Kissela BM,Khoury J,Kleindorfer D,et al.Epidemiology of ischemic stroke in patients with diabetes:the greater Cincinnati/Northern Kentucky Stroke Study[J].Diabetes Care,2005,28:355.
2Megherbi SE,Milan C,Minier D,et al.Association between diabetes and stroke on survival and functional outcome 3 months after stroke:data from the European Biomed[J].Stroke,2003,34:688.
4Burroughs V,Weinberger J.Diabetes and stroke:part two-treating diabetes and stress hyperglycemia in hospitalized stroke patients[J].Curr Cardiol Rep,2006,8(1):29.
5Lees KR,Walters MR.Acute stroke and diabetes[J].Cerebrovasc Dis,2005,20(Suppl 1):9.
6Zhu CZ,Auer RN.Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia[J].J Nnurosurg,2004,101:664.
7Adams JH,Adams RJ,Brott T,et al.Guidelines for the early management of patients with ischemic stroke.A scientific statement from the Stroke Council of the American Stroke Association[J].Stroke,2003,34:1056.
8Hacke W,Donnan G,Fieschi C,et al.Association of outcome with early stroke treatment:pooled analysis of ATLANTIS,ECASS,and NINDS rt-PA stroke trials[J].Lancet,2004,363:768.
9Hacke W,Albers G,Al-Rawi Y,et al.DIAS Study Group.The Desmoteplase in Acute Ischemic Stroke Trial(DIAS):a phase Ⅱ MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase[J].Stroke,2005,36:66.
